The Cardiovascular Research Foundation designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Documentation of awarded credit is provided for participants in exchange for completed activity evaluations. There is no registration fee for this CME activity. If you have previously registered and would like to return to the webcast, please click here.
 

FACULTY DISCLOSURES

KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E/S/O) Equity/Stock(s)/Options (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit

Planners

David Kandzari, MD – (G/R) Abbott Vascular, Boston Scientific, Medtronic CardioVascular, Biotronik, Orbus Neich, CSI, (C/H/S) Medtronic CardioVascular, CSI, (E/S/O) Biostar Ventures* (No equity related to Ablative Solutions)

Faculty

Felix Mahfoud, MD – (G/R) Deutsche Gesellschaft Für Fardiologie (DGK), Deutsche Forschungs Gemeinschaft (SFB TRR 219), Bayer, Boehringer Ingelheim, Medtronic, Recor Medical (C/H/S) Bayer, Boehringer Ingelheim, Medtronic, Recor Medical

 

 

This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted educational grant provided by Medtronic.